Zammit, Nathan W <br/><br/>
Low-dose rapamycin unmasks the protective potential of targeting intragraft NF-κB for islet transplants.  [electronic resource] 

 -  Cell transplantation  2013 
 - 2355-66 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1555-3892 
<br/><br/><label>Standard No.: </label>10.3727/096368912X658737  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cells, Cultured<br/>Chemokines--genetics<br/>Diabetes Mellitus, Experimental--mortality<br/>Drug Synergism<br/>Graft Survival--drug effects<br/>I-kappa B Kinase--genetics<br/>Immunosuppressive Agents--pharmacology<br/>Intercellular Adhesion Molecule-1--genetics<br/>Interleukin-6--genetics<br/>Islets of Langerhans--cytology<br/>Islets of Langerhans Transplantation<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Inbred C57BL<br/>NF-kappa B--antagonists & inhibitors<br/>Sirolimus--pharmacology<br/>Swine<br/>Transplantation, Homologous<br/>Tumor Necrosis Factor-alpha--genetics